Partnerships for Biodefense (R01)

Funding Opportunity RFA-AI-13-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites research applications for projects that support preclinical development of lead candidate therapeutics, vaccines and related technologies, or diagnostics against NIAID Category A, B, or C priority agents. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding